Status:
COMPLETED
the Effect of Isosorbide Mononitrate in Reducing Pain During Cooper Intrauterine Device Insertion
Lead Sponsor:
Cairo University
Conditions:
IUD Insertion Pain
Eligibility:
FEMALE
Phase:
PHASE3
Brief Summary
The aim of the study is to evaluate the efficacy of isosorbide mononitrate vaginal administration in reducing pain during copper IUD insertion in nulliparous women
Eligibility Criteria
Inclusion
- nulliparous women requesting copper IUD device insertion
Exclusion
- parous women, contraindications to IUD insertion, allergy or contraindication to isosorbide mononitrate, uterine anomaly
Key Trial Info
Start Date :
April 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04312048
Start Date
April 15 2020
End Date
November 30 2020
Last Update
January 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ahmed Samy
Giza, Egypt, 11231